Which is more profitable, CSL or Johnson & Johnson?

Johnson & Johnson keeps more of every sale as profit.

Which grows faster, CSL or Johnson & Johnson?

CSL grew its sales faster in recent years.

Which is cheaper, CSL or Johnson & Johnson?

CSL costs less for each unit of yearly profit (lower P/E).

Which has less debt, CSL or Johnson & Johnson?

Johnson & Johnson would need fewer years of earnings to pay off its debt.

CSLCSL.AXvs

Johnson & JohnsonJNJ

CSL vs Johnson & Johnson stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

CSL grows faster and is cheaper for its profits. Johnson & Johnson is more profitable and has less debt.

Side by side

	CSL	Johnson & Johnson
	A$97.4 billion	$688 billion
	19.5%	28.5%
	+13.7%	+2.7%
	22.0×	25.7×
	1.8 years	0.7 years
	9.3%	21.0%
	2.2%	2.3%

Open CSL Open Johnson & Johnson

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: CSL vs Eli Lilly · CSL vs Roche · CSL vs UnitedHealth · CSL vs AbbVie · Johnson & Johnson vs Gilead Sciences · Johnson & Johnson vs GSK · Johnson & Johnson vs Intuitive Surgical · Johnson & Johnson vs Eli Lilly